HeartSciences Inc
HSCS2.990USD
+0.180+6.32%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
9.18MMarket Cap
LossP/E TTM
More Details of HeartSciences Inc Company
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
HeartSciences Inc Info
Ticker SymbolHSCS
Company nameHeartSciences Inc
IPO dateJun 15, 2022
CEOSimpson (Andrew)
Number of employees15
Security typeOrdinary Share
Fiscal year-endJun 15
Address550 Reserve St, Suite 360
CitySOUTHLAKE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code76092
Phone16822377781
Websitehttps://heartsciences.com/
Ticker SymbolHSCS
IPO dateJun 15, 2022
CEOSimpson (Andrew)
Company Executives of HeartSciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.38K
+70000.00%
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-4416.00%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.38K
+70000.00%
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-4416.00%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
DRW Securities, LLC
2.63%
Simpson (Andrew)
2.34%
Icahn School of Medicine at Mount Sinai
1.53%
Matthews (John H)
1.25%
TFB Advisors LLC
0.94%
Other
91.32%
Shareholders
Shareholders
Proportion
DRW Securities, LLC
2.63%
Simpson (Andrew)
2.34%
Icahn School of Medicine at Mount Sinai
1.53%
Matthews (John H)
1.25%
TFB Advisors LLC
0.94%
Other
91.32%
Shareholder Types
Shareholders
Proportion
Investment Advisor
5.27%
Individual Investor
3.59%
Corporation
1.53%
Investment Advisor/Hedge Fund
0.40%
Research Firm
0.02%
Other
89.18%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
36
181.19K
5.70%
+77.68K
2025Q3
33
108.58K
3.54%
+49.69K
2025Q2
39
134.20K
6.56%
-24.66K
2025Q1
40
132.05K
12.22%
-6.21K
2024Q4
39
108.59K
11.08%
-22.21K
2024Q3
39
110.23K
11.34%
-17.15K
2024Q2
40
110.31K
22.15%
+69.79K
2024Q1
41
120.50K
23.97%
+81.89K
2023Q4
35
116.99K
23.49%
+83.22K
2023Q3
27
29.10K
27.79%
-2.40K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
DRW Securities, LLC
83.61K
2.63%
+83.61K
--
Sep 30, 2025
Simpson (Andrew)
74.38K
2.34%
+70.00K
+1597.44%
Nov 28, 2025
Icahn School of Medicine at Mount Sinai
48.55K
1.53%
--
--
Sep 24, 2024
Matthews (John H)
39.73K
1.25%
--
--
Sep 24, 2024
TFB Advisors LLC
29.74K
0.94%
+29.74K
--
Sep 30, 2025
Astoria Strategic Wealth, Inc.
18.93K
0.6%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
18.56K
0.58%
+17.24K
+1308.96%
Sep 30, 2025
Geode Capital Management, L.L.C.
12.78K
0.4%
+1.18K
+10.16%
Sep 30, 2025
Advisory Services Network, LLC
10.28K
0.32%
+277.00
+2.77%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
Date
Ex-dividend Date
Type
Ratio
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
May 15, 2024
Merger
100→1
